EA201990850A1 - MODULATOR OF A FLOW-MOVICIDE TRANSMEMBRANE CONDUCTIVITY REGULATOR, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND METHODS OF PRODUCING A MODULATOR - Google Patents
MODULATOR OF A FLOW-MOVICIDE TRANSMEMBRANE CONDUCTIVITY REGULATOR, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND METHODS OF PRODUCING A MODULATORInfo
- Publication number
- EA201990850A1 EA201990850A1 EA201990850A EA201990850A EA201990850A1 EA 201990850 A1 EA201990850 A1 EA 201990850A1 EA 201990850 A EA201990850 A EA 201990850A EA 201990850 A EA201990850 A EA 201990850A EA 201990850 A1 EA201990850 A1 EA 201990850A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- modulator
- methods
- pharmaceutical compositions
- movicide
- producing
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Описаны соединения формулы (I)их фармацевтически приемлемые соли, их дейтерированные производные и их метаболиты. Также раскрыты фармацевтические композиции, содержащие их, способы лечения муковисцидоза с их применением, а также способы их получения.The compounds of formula (I), their pharmaceutically acceptable salts, their deuterated derivatives and their metabolites are described. Also disclosed are pharmaceutical compositions containing them, methods for treating cystic fibrosis with their use, as well as methods for their preparation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662419935P | 2016-11-09 | 2016-11-09 | |
PCT/US2017/054611 WO2018064632A1 (en) | 2016-09-30 | 2017-09-29 | Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201990850A1 true EA201990850A1 (en) | 2019-09-30 |
Family
ID=68000208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201990850A EA201990850A1 (en) | 2016-11-09 | 2017-09-29 | MODULATOR OF A FLOW-MOVICIDE TRANSMEMBRANE CONDUCTIVITY REGULATOR, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND METHODS OF PRODUCING A MODULATOR |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA201990850A1 (en) |
-
2017
- 2017-09-29 EA EA201990850A patent/EA201990850A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA202091930A1 (en) | MACROCYCLES AS MODULATORS OF A FLUISCIDAL TRANSMEMBRANE CONDUCTIVITY REGULATOR, THEIR PHARMACEUTICAL COMPOSITIONS, THEIR APPLICATION FOR THE TREATMENT OF FLUISCIDOSIS AND THE METHOD OF THEIR MANUFACTURE | |
EA201991403A1 (en) | TRANSMEMBRANE CONDUCTIVITY REGULATOR MODULATOR FOR MUKOVISCIDOSIS, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND METHOD OF OBTAINING THE INDICATED MODULATOR | |
DOP2019000081A (en) | MODULATOR OF THE CHEMICAL FIBROSIS TRANSMEMBRANE DRIVING REGULATOR, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND PROCESS TO PRODUCE THE MODULATOR | |
EA202192704A1 (en) | DRUGS THAT MODULATE THE REGULATOR OF TRANSMEMBRANE CONDUCTIVITY IN CYSISTIC FIBRIOSIS | |
NZ768373A (en) | Modulators of cystic fibrosis transmembrane conductance regulator | |
EA201891191A1 (en) | 2-SUBSTITUTED HINAZOLIN COMPOUNDS CONTAINING A SUBSTITUTED HETEROCYCLIC GROUP AND METHODS OF THEIR APPLICATION | |
EA201692280A1 (en) | CONNECTIONS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY | |
EA201490864A1 (en) | DERIVATIVES (4-PHENYLIMIDAZOL-2-IL) ETYLAMINE AS SODIUM CHANNEL MODULATORS | |
EA201792594A1 (en) | POSITIVE ALLOSTERIC MODULATORS OF MUSARIN M1 RECEPTOR | |
EA201890684A1 (en) | FLUORINDOL DERIVATIVES AS A POSITIVE ALLOSTERIC MODULATORS OF MUSCARINE M1 RECEPTOR | |
EA201700356A1 (en) | NEW CYCLOPROPANBENZOFURANILPYRIDOPYRAZINDIONS | |
EA201990850A1 (en) | MODULATOR OF A FLOW-MOVICIDE TRANSMEMBRANE CONDUCTIVITY REGULATOR, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND METHODS OF PRODUCING A MODULATOR | |
CR20190211A (en) | Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator | |
EA201992719A1 (en) | Deuterated pyridone amides and their prodrugs as sodium channel modulators | |
EA201992153A1 (en) | Heteroaryl trifluoroborate compounds for the treatment of mycobacterial infections |